Page last updated: 2024-10-21

4-diphenylacetoxy-1,1-dimethylpiperidinium and Cardiovascular Stroke

4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Cardiovascular Stroke in 1 studies

4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, Y1
Jing, YH1
Sun, HL1
Li, HL1
Yang, BF1

Other Studies

1 other study available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Cardiovascular Stroke

ArticleYear
[Relationship between M3 receptor and myocyte apoptosis induced by acute myocardial infarction].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2004, Volume: 39, Issue:5

    Topics: Animals; Apoptosis; Choline; fas Receptor; Male; Malondialdehyde; Myocardial Infarction; Myocardium;

2004